Sequencing the viral genome? We'll help. As viral variants mutate and pose risk to our day-to-day lives, we understand the need for reliable chemistry that doesn’t require the time and expense of panel redesign. Join us during this webinar to learn how IDT xGen™ NGS solutions are leveraging xGen™ Amplicon and Adaptase™ technologies to aid in assessing novel variants for known viral pathogens, evaluating viral populations, and identifying novel viral genomes. In this session, you will:
Senior Director, Product Development,
Integrated DNA Technologies
Laurie received her PhD in Molecular Biology from Princeton University, followed by a post-doctorate with Shirley Tilghman focused on mammalian genomics and neurodegeneration. Prior to IDT, Laurie was a Senior VP of Product Development at Swift Biosciences where her R&D team developed the Swift NGS product portfolio, now re-branded within the IDT xGen product portfolio.
Senior Staff Scientist,
Integrated DNA Technologies
Jordan received her PhD in Chemistry from UC Berkeley where she studied enzyme mechanisms. During her post-doctorate at The Rockefeller University, she studied small molecule inhibitors of bacterial infection. Recently, Jordan has focused on targeted NGS sequencing, developing the xGen Amplicon Technology and numerous amplicon panels, including the xGen SARS-CoV-2 Amplicon Panel.